These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 12704236)
1. A macromolecular delivery vehicle for protein-based vaccines: acid-degradable protein-loaded microgels. Murthy N; Xu M; Schuck S; Kunisawa J; Shastri N; Fréchet JM Proc Natl Acad Sci U S A; 2003 Apr; 100(9):4995-5000. PubMed ID: 12704236 [TBL] [Abstract][Full Text] [Related]
2. Cytosolic Delivery of Liposomal Vaccines by Means of the Concomitant Photosensitization of Phagosomes. Hjálmsdóttir Á; Bühler C; Vonwil V; Roveri M; Håkerud M; Wäckerle-Men Y; Gander B; Johansen P Mol Pharm; 2016 Feb; 13(2):320-9. PubMed ID: 26704885 [TBL] [Abstract][Full Text] [Related]
3. Acid-degradable particles for protein-based vaccines: enhanced survival rate for tumor-challenged mice using ovalbumin model. Standley SM; Kwon YJ; Murthy N; Kunisawa J; Shastri N; Guillaudeu SJ; Lau L; Fréchet JM Bioconjug Chem; 2004; 15(6):1281-8. PubMed ID: 15546194 [TBL] [Abstract][Full Text] [Related]
4. Directed antigen presentation using polymeric microparticulate carriers degradable at lysosomal pH for controlled immune responses. Kwon YJ; Standley SM; Goodwin AP; Gillies ER; Fréchet JM Mol Pharm; 2005; 2(1):83-91. PubMed ID: 15804181 [TBL] [Abstract][Full Text] [Related]
5. Acid-degradable polyurethane particles for protein-based vaccines: biological evaluation and in vitro analysis of particle degradation products. Bachelder EM; Beaudette TT; Broaders KE; Paramonov SE; Dashe J; Fréchet JM Mol Pharm; 2008; 5(5):876-84. PubMed ID: 18710254 [TBL] [Abstract][Full Text] [Related]
6. A protective vaccine delivery system for in vivo T cell stimulation using nanoengineered polymer hydrogel capsules. Sexton A; Whitney PG; Chong SF; Zelikin AN; Johnston AP; De Rose R; Brooks AG; Caruso F; Kent SJ ACS Nano; 2009 Nov; 3(11):3391-400. PubMed ID: 19824668 [TBL] [Abstract][Full Text] [Related]
13. Microgel-in-Microgel Biopolymer Delivery Systems: Controlled Digestion of Encapsulated Lipid Droplets under Simulated Gastrointestinal Conditions. Ma D; Tu ZC; Wang H; Zhang Z; McClements DJ J Agric Food Chem; 2018 Apr; 66(15):3930-3938. PubMed ID: 29595967 [TBL] [Abstract][Full Text] [Related]
14. Synthesis of protein-loaded hydrogel particles in an aqueous two-phase system for coincident antigen and CpG oligonucleotide delivery to antigen-presenting cells. Jain S; Yap WT; Irvine DJ Biomacromolecules; 2005; 6(5):2590-600. PubMed ID: 16153096 [TBL] [Abstract][Full Text] [Related]
15. Enhanced generation of cytotoxic T lymphocytes by heat shock protein 70 fusion proteins harboring both CD8(+) T cell and CD4(+) T cell epitopes. Takemoto S; Nishikawa M; Guan X; Ohno Y; Yata T; Takakura Y Mol Pharm; 2010 Oct; 7(5):1715-23. PubMed ID: 20695521 [TBL] [Abstract][Full Text] [Related]
16. Stable and degradable microgels linked with cystine for storing and environmentally triggered release of drugs. Mackiewicz M; Kaniewska K; Romanski J; Augustin E; Stojek Z; Karbarz M J Mater Chem B; 2015 Sep; 3(36):7262-7270. PubMed ID: 32262834 [TBL] [Abstract][Full Text] [Related]
17. Particulate formulations for the delivery of poly(I:C) as vaccine adjuvant. Hafner AM; Corthésy B; Merkle HP Adv Drug Deliv Rev; 2013 Oct; 65(10):1386-99. PubMed ID: 23751781 [TBL] [Abstract][Full Text] [Related]
18. Nanoparticles built by self-assembly of amphiphilic gamma-PGA can deliver antigens to antigen-presenting cells with high efficiency: a new tumor-vaccine carrier for eliciting effector T cells. Yoshikawa T; Okada N; Oda A; Matsuo K; Matsuo K; Kayamuro H; Ishii Y; Yoshinaga T; Akagi T; Akashi M; Nakagawa S Vaccine; 2008 Mar; 26(10):1303-13. PubMed ID: 18255205 [TBL] [Abstract][Full Text] [Related]
19. Electroactive and degradable supramolecular microgels. Li H; Mergel O; Jain P; Li X; Peng H; Rahimi K; Singh S; Plamper FA; Pich A Soft Matter; 2019 Oct; 15(42):8589-8602. PubMed ID: 31642835 [TBL] [Abstract][Full Text] [Related]
20. Functional characterization of biodegradable nanoparticles as antigen delivery system. Petrizzo A; Conte C; Tagliamonte M; Napolitano M; Bifulco K; Carriero V; De Stradis A; Tornesello ML; Buonaguro FM; Quaglia F; Buonaguro L J Exp Clin Cancer Res; 2015 Oct; 34():114. PubMed ID: 26444005 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]